KELLI BRISTER: Open Payments
NPI 1366954240 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$490 in 18 payments from 8 companies in 2025. Trend: 2023 $602 · 2024 $961 · 2025 $490
Food & beverage: $490
| Company | Payments | Amount |
|---|---|---|
| Viatris Specialty LLC | 5 | $120 |
| AstraZeneca Pharmaceuticals LP | 1 | $119 |
| ABBVIE INC. | 6 | $114 |
| PFIZER INC. | 2 | $45 |
| Alexion Pharmaceuticals, Inc. | 1 | $34 |
| ABIOMED | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Amgen Inc. | 1 | $15 |
Products named: YUPELRI, LOKELMA, TEFLARO, ULTOMIRIS, AVYCAZ, ELIQUIS, NURTEC ODT, VERQUVO.
Industry payments across MS — which companies pay providers there.
